Cyborg | Designer-Babies | Futurism | Futurist | Immortality | Longevity | Nanotechnology | Post-Human | Singularity | Transhuman

Stem Cell Cure for “Bubble Baby” Disease (SCID), Pioneered by UCLA's Don Kohn
On November 18th, 2014, a UCLA research team led by Donald Kohn, M.D., announced a breakthrough gene therapy and stem cell cure for “bubble baby” disease, or severe combined …

By: California Institute for Regenerative Medicine

Read the original post:
Stem Cell Cure for "Bubble Baby" Disease (SCID), Pioneered by UCLA’s Don Kohn – Video

How does Regenerative Medicine work?

When soft tissue is damaged, the bodys natural response is to deliver platelets to the area of injury. Platelets release growth factors, which promote the repair and regeneration of connective tissue, and call stem cells to the damaged area. With Platelet Rich Plasma (PRP), a small amount of blood is drawn from the patients body and placed in a centrifuge to concentrate the platelets. When more of a stem cell load is required, fat and/or bone marrow can be combined with the PRP to create an Autologous Regenerative Matrix (ARM). The PRP, fat, and/or bone marrow are then injected into the damaged tissue, jump-starting the bodys natural healing process, allowing for tissue regeneration without the use of surgery.

Commonly treated areas

Commonly treated conditions

What are the advantages?

What are the expected results?

The bodys natural healing response is jump-started via the inflammatory cascade. Therefore, there is a temporary increase in pain with the initial inflammation up to a couple weeks. This inflammatory pain does resolve and improvement begins. Tendons are stronger within five days, and there is a gradual increase in the normalization of the damaged tissue with time.

Joseph J. Albano, M.D. Salt Lake Regional Medical Center

Originally posted here:
HealthFix Regenerative Medicine: What it is and how it can help you?

SAN DIEGO, Nov. 20, 2014 /PRNewswire/ — ViaCyte, Inc., a privately-held regenerative medicine company developing a stem cell-derived islet replacement therapy for the treatment of diabetes, today announced …

Read the rest here:
ViaCyte to Present at 26th Annual Piper Jaffray Healthcare Conference



Contact: Scott LaFee 619-543-5232 University of California – San Diego @UCSanDiego

While investigating a rare genetic disorder, researchers at the University of California, San Diego School of Medicine have discovered that a ubiquitous signaling molecule is crucial to cellular reprogramming, a finding with significant implications for stem cell-based regenerative medicine, wound repair therapies and potential cancer treatments.

The findings are published in the Nov. 20 online issue of Cell Reports.

Karl Willert, PhD, assistant professor in the Department of Cellular and Molecular Medicine, and colleagues were attempting to use induced pluripotent stem cells (iPSC) to create a “disease-in-a-dish” model for focal dermal hypoplasia (FDH), a rare inherited disorder caused by mutations in a gene called PORCN. Study co-authors V. Reid Sutton and Ignatia Van den Veyver at Baylor College of Medicine had published the observation that PORCN mutations underlie FDH in humans in 2007.

FDH is characterized by skin abnormalities such as streaks of very thin skin or different shades, clusters of visible veins and wartlike growths. Many individuals with FDH also suffer from hand and foot abnormalities and distinct facial features. The condition is also known as Goltz syndrome after Robert Goltz, who first described it in the 1960s. Goltz spent the last portion of his career as a professor at UC San Diego School of Medicine. He retired in 2004 and passed away earlier this year.

To their surprise, Willert and colleagues discovered that attempts to reprogram FDH fibroblasts or skin cells with the requisite PORCN mutation into iPSCs failed using standard methods, but succeeded when they added WNT proteins – a family of highly conserved signaling molecules that regulate cell-to-cell interactions during embryogenesis.

“WNT signaling is ubiquitous,” said Willert. “Every cell expresses one or more WNT genes and every cell is able to receive WNT signals. Individual cells in a dish can grow and divide without WNT, but in an organism, WNT is critical for cell-cell communication so that cells distinguish themselves from neighbors and thus generate distinct tissues, organs and body parts.”

WNT signaling is also critical in limb regeneration (in some organisms) and tissue repair.

Read the original post:
Signaling molecule crucial to stem cell reprogramming

MENLO PARK, Calif., Nov. 18, 2014 /PRNewswire/ –Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading biotechnology company in the emerging field of regenerative medicine, today announced that the …

The rest is here:
Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at the Therapeutic …

MARIETTA, Ga., Nov. 17, 2014 /PRNewswire/ –MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market …

See original here:
Multi-Center Comparative Study Of MiMedx EpiFix And Organogenesis Apligraf Determines EpiFix Has Considerably Higher …

MENLO PARK, Calif., Nov. 17, 2014 /PRNewswire/ — Asterias Biotherapeutics, Inc. (NYSE MKT: AST), a leading biotechnology company in the emerging field of regenerative medicine, today announced that Jane …

The rest is here:
Asterias Biotherapeutics to Participate in Live Google Hangout Discussion of Stem Cell-Based Therapies for Spinal Cord …

Eli Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA
In a specially designed facility that is compliant with FDA Good Manufacturing Practices (GMP) requirements, scientists with the Eli and Edythe Center of Regenerative Medicine and Stem Cell…

By: UCLA Eli Edythe Broad Center of Regenerative Medicine and Stem Cell Research

Read the original:
Eli & Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA – Video

Innovation (Re)Generation: Exploring Regenerative Medicine
Over recent years, considerable interest has been developing in regard to therapies that have become and may become available based on what is known as 'regenerative medicine' (RM). Currently,…

By: Mason Institute

Innovation (Re)Generation: Exploring Regenerative Medicine – Video

Science Documentary: Stem Cells,Regenerative Medicine,Artificial Heart,a future medicine documentary
Science Documentary: Stem Cells,Regenerative Medicine,Artificial Heart,a future medicine documentary In each and every one of our organs and tissue, we have stem cells. These stem cells…

By: ScienceRound

Continued here:
Science Documentary: Stem Cells,Regenerative Medicine,Artificial Heart,a future medicine documentary – Video

Welcome Remarks – Roger Bingham
Speaker: Roger Bingham, Co-Founder Director, The Science Network; Member, Computational Neurobiology Laboratory, Salk Institute for Biological Studies.

By: Alliance for Regenerative Medicine

Go here to read the rest:
Welcome Remarks – Roger Bingham – Video

The Good Doctor – The Secret behind Regenerative Medicine As always please “LIKE” this video, subscribe to our channel and join us on Facebook and Twitter below! Facebook Twitter…


The Good Doctor – The Secret behind Regenerative Medicine – Video

MOUNTAIN VIEW, Calif., Nov. 11, 2014 /PRNewswire/ — WHAT: "Regenerative Medicine & Cell Therapy – Multi-Billion Industries with Unlimited Potential" Panel at the 2014 World Stem Cell Summit …

Original post:
The New Age of Regenerative Medicine: Are Stem Cells the Future of Healing?

MIAMI (PRWEB) November 11, 2014

GlobalStemCellsGroup, Inc. has announced plans to host a minimum of four international symposiums on stem cell research in 2015. The symposiums will be held in three Latin American countriesChile, Mexico and Colombiain which Global Stem Cells has established state-of-the-art stem cell clinics staffed with expert medical personnel trained in regenerative medicine, through the Regenestem Network.

The fourth symposium will be held in Miami.

The decision follows the success of the Global Stem Cells Groups first International Symposium on Stem Cells and Regenerative Medicine, held Oct. 2, 3 and 4 in Buenos Aires, Argentina. Global Stem Cells Group CEO Benito Novas says the Buenos Aires event, combined with its steady growth of new clinics throughout Latin America, has provided additional motivation to schedule more stem cell symposiums in an effort to further educate the medical community on the latest advancements in stem cell therapies.

Thanks to Global Stem Cells Groups growing network of world-class stem cell researchers, treatment practitioners and investors committed to advancing stem cell medicine, the company is rapidly moving closer to its goal of helping physicians to bring treatments into their offices for the benefit of patients.

More than 900 physicians, researchers and regenerative medicine experts from around the world attended the Buenos Aires symposium, and Novas expects that number to grow with upcoming conferences.

We will continue to bring together a variety of committed stem cell advocates from the U.S., Mexico, Greece, Hong Kong and other regions around the globe, to be joined by a team of knowledgeable speakers, each one presenting the future of regenerative medicine in their field of specialty, Novas says.

Regenerative medicine as a field is still in its infancy, according to Global Stem Cell Group President and CEO Benito Novas.

Our objective is to [open a dialogue among the worlds medical and scientific communities in order to advance stem cell technologies and translate them into point of care medicine to the best of out abilities, Novas says. Our mission is to bring the benefits of stem cell therapies to the physicians office safely, efficacy and compliance with the highest standards of care with safety, efficacy and complying with the highest standard of care the world has to offer.

The purpose of each symposium is to bring top stem cell scientists together to share their knowledge and expertise in regenerative medicine, and begin the process of separating myths from facts when it comes to stem cell science and technology.

View post:
Global Stem Cells Group Announces Plans to Hold Four International Symposiums on Stem Cells and Regenerative Medicine …

ST. LOUIS, Nov. 11, 2014 /PRNewswire/ –ISTO Technologies, Inc., a privately-held regenerative medicine company, announced that George Dunbar, the Company's President and Chief Executive Officer, will …

Read this article:
ISTO to Present at 2014 Stifel Healthcare Conference

Modeling Human Disease – Panel Discussion
The increasing ease with which accessible cells (e.g., blood, skin) from a given patient can be reprogrammed and redirected to assume the phenotype of a dise…

By: Alliance for Regenerative Medicine

See original here:
Modeling Human Disease – Panel Discussion – Video

Engineering Microenvironments for Stem Cells – Shaochen Chen, UC San Diego
Speaker: Shaochen Chen, Ph.D., Professor, NanoEngineering Bioengineering; Co-Director, Biomaterials Tissue Engineering Center, UC San Diego.

By: Alliance for Regenerative Medicine

View original post here:
Engineering Microenvironments for Stem Cells – Shaochen Chen, UC San Diego – Video

Home Mail News Sports Finance Weather Games Groups Answers Screen Flickr Mobile More Celebrity Movies Music TV Health Style Beauty Food Parenting DIY Tech Shopping Travel Autos Homes Sign In Mail Help Account Info Help Suggestions

Read more:
The Alliance for Regenerative Medicine Elects Edward Lanphier as Chairman, Welcomes New Officers and Executive …

RICHMOND, Calif., Nov. 10, 2014 /PRNewswire/ — Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced that Edward Lanphier, the Company's president and CEO, has been elected to serve as the next Chairman …

Continued here:
Sangamo BioSciences President and CEO Edward Lanphier to Serve as Chairman of the Alliance for Regenerative Medicine

FireFox! Start Your Own Web Hosting Company
Web Hosting Advertise Here $10 a Month Affordable web-hosting
Pierre Teilhard De Chardin

Designer Children | Prometheism | Euvolution | Transhumanism

Sign up below for the Prometheism / Designer Children Discussion Forum

Subscribe to prometheism-pgroup

Powered by